Skip to content
May 12, 2024

Equity.Guru

Investment information for the new generation

Search

Science

I’ll admit that I’m beginning to have my suspicions about the psychedelic sector. The question I’ve started asking when I look at a new psychedelics company is where’s the…
Delic Holdings (DELC.C) announced their recently acquired entity Complex Biotech Discovery Ventures (CBDV) has been rebranded as Delic Labs. Delic Labs is a federally authorized psilocybin and cannabis research…
Cybin (CYBN.NE) announced that their wholly-owned subsidiary, Adelia Therapeutics, has achieved certain earn-out milestones for the period commencing January 1, 2021. The terms of the milestone earnings were agreed…
Mind Medicine (MNMD.Q) announced the addition of Dr. Peter Bergethon to their Scientific Advisory Board. Bergethon is a “world-leading” expert in neurology, digital medicine, and central nervous system (CNS)…
When you write about the psychedelics industry, most of the people you speak with are corporate executives and most of what you read comes from PR personnel, so speaking…
Mind Medicine (MMED.NE) announced the publication of the first pharmacogenetic data on LSD to help personalize dosing. The study results from a pooled secondary analysis of four Phase I…
Delic Holdings (DELC.C) announced that their acquisition target, Complex Biotech Discovery Ventures (CBDV), has hired Dr. Eric Janusson as their Lead Chemist. Dr. Eric Janusson is an analytical organometallic…
Cybin (CYBN.NE) announced they are forming a Clinical Advisory Board, which will be chaired by Alex Belser, Cybin’s Chief Clinical Officer. The board will consist of Belser (PhD), Maurizio…
50 years I’ve been bumbling around this planet, and the best damn weekend I’ve had on it to date occurred recently, under the influence of mushrooms. The carpet didn’t…
The Green Organic Dutchman (TGOD.T) has appointed Dr. Ray Kumar as its new chief science officer. TGOD’s latest science-related appointment adds onto their most recent board-shuffle earlier this month….